logo
food for the brain

Championing optimum nutrition for the mind


A review of the current evidence (2005) suggests that essential fatty acids, particularly EPA and DHA may benefit a variety of mental health conditions. Peet & Stokes, Drugs, 65(8):1051-9, 2005

Paper

 

A review of the current evidence (2005) suggests that essential fatty acids, particularly EPA and DHA may benefit a variety of mental health conditions. Peet & Stokes, Drugs, 65(8):1051-9, 2005

Details

A review finds that: there is an association between depression and low dietary intake of omega-3 fatty acids and that low levels of the fatty acids in red blood cell membranes are found in both depressive and schizophrenic patients. Five of six double-blind, placebo-controlled trials in schizophrenia, and four of six such trials in depression, have reported therapeutic benefit from omega-3 fatty acids in particularly when EPA is added on to existing psychotropic medication. Individual clinical trials have suggested benefits of EPA treatment in borderline personality disorder and of combined omega-3 and omega-6 fatty acid treatment for attention-deficit hyperactivity disorder. The evidence to date supports the use of omega-3 fatty acids in the management of treatment unresponsive depression and schizophrenia alongside medication. As these conditions are associated with increased risk of coronary heart disease and diabetes mellitus, omega-3 fatty acids should also benefit the physical state of these patients.

Peet & Stokes, ‘Omega-3 fatty acids in the treatment of psychiatric disorders ‘, Drugs, 65(8):1051-9, 2005

Click here for the abstract